Q3 2025 Earnings Call November 5, 2025 8:30 AM ESTCompany ParticipantsAlex Giaimo - Head of Investor RelationsMatthew Bromberg ...

The manuscript concerns a fundamental and controversial question in Trypanosoma brucei biology and the parasite life cycle, providing further evidence that slender bloodstream forms can indeed infect ...

WM , North America's leading environmental solutions provider and largest recycler, has added plastic cups made of polypropylene and paper to-go cups to its universal list of accepted recyclable ...

Learn more about whether BioMarin Pharmaceutical Inc. or Amicus Therapeutics, Inc. is a better investment based on AAII's A+ ...

Revenue Increases to $18.6 Million, up 8% Y/Y Delivers Cash Flow from Operations of $0.6 million and Adjusted EBITDA of $1.1 million AI Teaching Assistant ...

Learn more about whether Alkermes plc or BioMarin Pharmaceutical Inc. is a better investment based on AAII's A+ Investor ...

Completed rolling Biologics License Application (BLA) submission seeking accelerated approval for lead candidate INO-3107; requested priority review ...

Ralliant Corporation ( RAL) Q3 2025 Earnings Call November 6, 2025 8:30 AM EST Hello. My name is Donna, and I will be your conference facilitator this morning. At this time, I would like to welcome ...

Failure by municipal and national govern­ments in any given country to provide adequately for the needs of both small, medium and large business enterprises can significantly reduce the po­tential of ...

Detailed price information for Kintavar Exploration Inc (KTR-X) from The Globe and Mail including charting and trades.

During the third quarter of 2025, the company repurchased 2.0 million shares of its common stock through open market transactions for $50.0 million. At September 30, 2025, the company had $200.0 ...

Dynavax Technologies Corporation , a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines, today reported financial results and provided a business update for ...